Skip to main content
Erschienen in: Archives of Virology 1/2018

05.10.2017 | Original Article

Human papillomavirus genotype distribution among HPV-positive women in Sichuan province, Southwest China

verfasst von: Guo Tao, Gao Yaling, Gao Zhan, Liao Pu, He Miao

Erschienen in: Archives of Virology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

In this hospital-based descriptive study, the genotype distribution of human papillomavirus (HPV) among HPV-infected women were investigated in 4,305 gynecological patients in Sichuan province. Females attending gynecology clinics between March 2014 and March 2015 were subjected to HPV screening after giving informed consent. Cervical scrapings were examined by cytopathology and colposcopy-directed biopsies. HPV genotyping was performed on a Luminex 200 system. Seventeen high-risk (HR) genotypes (HPV-16, -18, -31, -33, -35, -39, -45, -51, -52, -53, -56, -58, -59, -66, -68, -73, and -82) and seven low-risk (LR) genotypes (HPV-6, -11, -42, -43, -61, -81, and -83) were detected. Among all HPV-positive women, 34.1% (1,467/4,305) of the cases showed abnormal cytology and biopsy, including high-grade squamous lesions (HSIL), cervical intraepithelial neoplasias of grades 2 and 3 (CIN2/CIN3), and cervical cancer (CC). HPV-16, -52, and -58 were the predominant genotypes, followed by HPV-56, -18, -59, -39, -53, -33, and -81. A total of 3,785 (87.9%) HPV positive women were found to have HR HPV infection, while 859 (20.0%) were found to have LR HPV infection. Among all patients, 79% (3,401/4,305) were infected with a single strain of HPV, 85.5% (2,907/3,401) cases of which were of the HR HPV genotype. In cervical precancerous lesions (CPLs) and CC patients, HR HPV-16, -58, -52, -33, and -18 were the predominant genotypes. Interestingly, 33 CPL patients had a single LR HPV infection with HPV-61, -11, -81, -6, -43, or -42. Furthermore, one CC patient was infected only with LR HPV-11. According to the abundant genotype diversity of HPV in Sichuan, we suggest that a large-scale epidemiological investigation should be launched, not only to understand the distribution of HPV genotype, but also to provide information needed for HPV vaccination programs and to predict the effectiveness of current vaccines in Southwest China.
Literatur
1.
Zurück zum Zitat An HJ, Cho NH, Lee SY, Kim IH, Lee C, Kim SJ, Mun MS, Kim SH, Jeong JK (2003) Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 97(7):1672–1680CrossRefPubMed An HJ, Cho NH, Lee SY, Kim IH, Lee C, Kim SJ, Mun MS, Kim SH, Jeong JK (2003) Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 97(7):1672–1680CrossRefPubMed
2.
Zurück zum Zitat Bachtiary B, Obermair A, Dreier B, Birner P, Breitenecker G, Knocke TH, Selzer E, Potter R (2002) Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer. Int J Cancer 102:237–243CrossRefPubMed Bachtiary B, Obermair A, Dreier B, Birner P, Breitenecker G, Knocke TH, Selzer E, Potter R (2002) Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer. Int J Cancer 102:237–243CrossRefPubMed
3.
Zurück zum Zitat Baloch Z, Yuan T, Wang B, Tai W, Feng Y, Liu Y, Li X, Feng Y, Liu L, Zhang AM, Wu X, Xia X (2016) Ethnic and geographic variations in HPV prevalence and genotype distribution in north-western Yunnan, China. J Med Virol 88:532–540CrossRefPubMed Baloch Z, Yuan T, Wang B, Tai W, Feng Y, Liu Y, Li X, Feng Y, Liu L, Zhang AM, Wu X, Xia X (2016) Ethnic and geographic variations in HPV prevalence and genotype distribution in north-western Yunnan, China. J Med Virol 88:532–540CrossRefPubMed
4.
Zurück zum Zitat Baloch Z, Yuan T, Yindi S, Feng Y, Tai W, Liu Y, Liu L, Zhang A, Wang B, Wu X, Xia X (2016) Prevalence of genital human papillomavirus among rural and urban populations in southern Yunnan province, China. Braz J Med Biol Res 49:e5254CrossRefPubMedPubMedCentral Baloch Z, Yuan T, Yindi S, Feng Y, Tai W, Liu Y, Liu L, Zhang A, Wang B, Wu X, Xia X (2016) Prevalence of genital human papillomavirus among rural and urban populations in southern Yunnan province, China. Braz J Med Biol Res 49:e5254CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Bao YP, Li N, Smith JS, Qiao YL, Members A (2008) Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer 18:71–79CrossRefPubMed Bao YP, Li N, Smith JS, Qiao YL, Members A (2008) Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer 18:71–79CrossRefPubMed
6.
Zurück zum Zitat Basu P, Chandna P, Bamezai RN, Siddiqi M, Saranath D, Lear A, Ratnam S (2011) MassARRAY spectrometry is more sensitive than PreTect HPV-Proofer and consensus PCR for type-specific detection of high-risk oncogenic human papillomavirus genotypes in cervical cancer. J Clin Microbiol 49:3537–3544CrossRefPubMedPubMedCentral Basu P, Chandna P, Bamezai RN, Siddiqi M, Saranath D, Lear A, Ratnam S (2011) MassARRAY spectrometry is more sensitive than PreTect HPV-Proofer and consensus PCR for type-specific detection of high-risk oncogenic human papillomavirus genotypes in cervical cancer. J Clin Microbiol 49:3537–3544CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V, Group WHOIAfRoCMW (2009) A review of human carcinogens—part B: biological agents. Lancet Oncol 10:321–322CrossRefPubMed Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V, Group WHOIAfRoCMW (2009) A review of human carcinogens—part B: biological agents. Lancet Oncol 10:321–322CrossRefPubMed
8.
Zurück zum Zitat Brandstetter T, Bohmer S, Prucker O, Bisse E, zur Hausen A, Alt-Morbe J, Ruhe J (2010) A polymer-based DNA biochip platform for human papilloma virus genotyping. J Virol Methods 163:40–48CrossRefPubMed Brandstetter T, Bohmer S, Prucker O, Bisse E, zur Hausen A, Alt-Morbe J, Ruhe J (2010) A polymer-based DNA biochip platform for human papilloma virus genotyping. J Virol Methods 163:40–48CrossRefPubMed
9.
Zurück zum Zitat Ceccato Junior BP, Guimaraes MD, Lopes AP, Nascimento LF, Novaes LM, Del Castillo DM, Melo VH (2016) Incidence of cervical human papillomavirus and cervical intraepithelial neoplasia in women with positive and negative HIV status. Rev Bras Ginecol Obstet 38:231–238CrossRefPubMed Ceccato Junior BP, Guimaraes MD, Lopes AP, Nascimento LF, Novaes LM, Del Castillo DM, Melo VH (2016) Incidence of cervical human papillomavirus and cervical intraepithelial neoplasia in women with positive and negative HIV status. Rev Bras Ginecol Obstet 38:231–238CrossRefPubMed
10.
Zurück zum Zitat Chen Z, Wang Q, Ding X, Li Q, Zhong R, Ren H (2015) Characteristics of HPV prevalence in Sichuan Province, China. Int J Gynaecol Obstet 131:277–280CrossRefPubMed Chen Z, Wang Q, Ding X, Li Q, Zhong R, Ren H (2015) Characteristics of HPV prevalence in Sichuan Province, China. Int J Gynaecol Obstet 131:277–280CrossRefPubMed
11.
Zurück zum Zitat Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S, Group IHPSS (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366:991–998CrossRefPubMed Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S, Group IHPSS (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366:991–998CrossRefPubMed
12.
Zurück zum Zitat Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJ, Huang RD, Sun LX, Meijer CJ, Qiao YL, Franceschi S (2006) Human papillomavirus infection in Shanxi Province, People’s Republic of China: a population-based study. Br J Cancer 95:96–101CrossRefPubMedPubMedCentral Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJ, Huang RD, Sun LX, Meijer CJ, Qiao YL, Franceschi S (2006) Human papillomavirus infection in Shanxi Province, People’s Republic of China: a population-based study. Br J Cancer 95:96–101CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefPubMed
14.
Zurück zum Zitat Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD (2005) Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 191:1796–1807CrossRefPubMed Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD (2005) Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 191:1796–1807CrossRefPubMed
15.
Zurück zum Zitat Hibbitts S, Rieck GC, Hart K, Powell NG, Beukenholdt R, Dallimore N, McRea J, Hauke A, Tristram A, Fiander AN (2006) Human papillomavirus infection: an anonymous prevalence study in South Wales, UK. Br J Cancer 95:226–232CrossRefPubMedPubMedCentral Hibbitts S, Rieck GC, Hart K, Powell NG, Beukenholdt R, Dallimore N, McRea J, Hauke A, Tristram A, Fiander AN (2006) Human papillomavirus infection: an anonymous prevalence study in South Wales, UK. Br J Cancer 95:226–232CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, Hutchinson M, Balmaceda I, Greenberg M, Schiffman M (2001) HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 84:1219–1226CrossRefPubMedPubMedCentral Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, Hutchinson M, Balmaceda I, Greenberg M, Schiffman M (2001) HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 84:1219–1226CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Hildesheim A, Wang SS (2002) Host and viral genetics and risk of cervical cancer: a review. Virus Res 89:229–240CrossRefPubMed Hildesheim A, Wang SS (2002) Host and viral genetics and risk of cervical cancer: a review. Virus Res 89:229–240CrossRefPubMed
18.
Zurück zum Zitat Humans IWGotEoCRt (2012) Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 100:1–441 Humans IWGotEoCRt (2012) Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 100:1–441
19.
Zurück zum Zitat International Collaboration of Epidemiological Studies of Cervical C (2006) Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer 119:1108–1124CrossRef International Collaboration of Epidemiological Studies of Cervical C (2006) Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer 119:1108–1124CrossRef
20.
Zurück zum Zitat Kahn JA, Burk RD, Squires KE, Kapogiannis BG, Rudy B, Xu J, Gonin R, Liu N, Worrell C, Wilson CM (2012) Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination. J Acquir Immune Defic Syndr 61:390–399CrossRefPubMedPubMedCentral Kahn JA, Burk RD, Squires KE, Kapogiannis BG, Rudy B, Xu J, Gonin R, Liu N, Worrell C, Wilson CM (2012) Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination. J Acquir Immune Defic Syndr 61:390–399CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Kirschner B, Junge J, Holl K, Rosenlund M, Collas de Souza S, Quint W, Molijn A, Jenkins D, Schledermann D (2013) HPV genotypes in invasive cervical cancer in Danish women. Acta Obstet Gynecol Scand 92:1023–1031CrossRefPubMed Kirschner B, Junge J, Holl K, Rosenlund M, Collas de Souza S, Quint W, Molijn A, Jenkins D, Schledermann D (2013) HPV genotypes in invasive cervical cancer in Danish women. Acta Obstet Gynecol Scand 92:1023–1031CrossRefPubMed
22.
Zurück zum Zitat Li J, Zhang D, Zhang Y, Wang X, Lin Y, Hu L (2011) Prevalence and genotype distribution of human papillomavirus in women with cervical cancer or high-grade precancerous lesions in Chengdu, western China. Int J Gynaecol Obstet 112:131–134CrossRefPubMed Li J, Zhang D, Zhang Y, Wang X, Lin Y, Hu L (2011) Prevalence and genotype distribution of human papillomavirus in women with cervical cancer or high-grade precancerous lesions in Chengdu, western China. Int J Gynaecol Obstet 112:131–134CrossRefPubMed
23.
Zurück zum Zitat Nakagawa M, Spencer HJ, Coleman HN, Greenfield WW (2013) Distribution of human papillomavirus (HPV) types and anti-HPV T-cell immune responses among different racial/ethnic groups in Central Arkansas. J Ark Med Soc 109:160–163PubMedPubMedCentral Nakagawa M, Spencer HJ, Coleman HN, Greenfield WW (2013) Distribution of human papillomavirus (HPV) types and anti-HPV T-cell immune responses among different racial/ethnic groups in Central Arkansas. J Ark Med Soc 109:160–163PubMedPubMedCentral
24.
Zurück zum Zitat Li N, Dai M (2008) Human papillomavirus infection in China: a multi-centric cross-sectional study. Chin J Dis Control Prev 12:411–415 Li N, Dai M (2008) Human papillomavirus infection in China: a multi-centric cross-sectional study. Chin J Dis Control Prev 12:411–415
25.
Zurück zum Zitat Shikary T, Bernstein DI, Jin Y, Zimet GD, Rosenthal SL, Kahn JA (2009) Epidemiology and risk factors for human papillomavirus infection in a diverse sample of low-income young women. J Clin Virol 46:107–111CrossRefPubMedPubMedCentral Shikary T, Bernstein DI, Jin Y, Zimet GD, Rosenthal SL, Kahn JA (2009) Epidemiology and risk factors for human papillomavirus infection in a diverse sample of low-income young women. J Clin Virol 46:107–111CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19CrossRefPubMed Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19CrossRefPubMed
27.
Zurück zum Zitat Wang L, Wang P, Ren Y, Du J, Jiang J, Jia X, Chen C, Wang Y (2016) Prevalence of high-risk human papillomavirus (HR-HPV) genotypes and multiple infections in cervical abnormalities from Northern Xinjiang, China. PLoS One 11:e0160698CrossRefPubMedPubMedCentral Wang L, Wang P, Ren Y, Du J, Jiang J, Jia X, Chen C, Wang Y (2016) Prevalence of high-risk human papillomavirus (HR-HPV) genotypes and multiple infections in cervical abnormalities from Northern Xinjiang, China. PLoS One 11:e0160698CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Zhang HY, Fei MD, Jiang Y, Fei QY, Qian H, Xu L, Jin YN, Jiang CQ, Li HX, Tiggelaar SM, Smith JS, Sahasrabuddhe VV, Qiao YL (2014) The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China. Virol J 11:202CrossRefPubMedPubMedCentral Zhang HY, Fei MD, Jiang Y, Fei QY, Qian H, Xu L, Jin YN, Jiang CQ, Li HX, Tiggelaar SM, Smith JS, Sahasrabuddhe VV, Qiao YL (2014) The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China. Virol J 11:202CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang QM, Wu RF, Li CQ, Wei LH, Xu AD, Zhang WH, Pan QJ, Zhang X, Belinson JL, Sellors JW, Smith JS, Qiao YL, Franceschi S (2012) Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer 131:2929–2938CrossRefPubMedPubMedCentral Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang QM, Wu RF, Li CQ, Wei LH, Xu AD, Zhang WH, Pan QJ, Zhang X, Belinson JL, Sellors JW, Smith JS, Qiao YL, Franceschi S (2012) Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer 131:2929–2938CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Zhao R, Zhang WY, Wu MH, Zhang SW, Pan J, Zhu L, Zhang YP, Li H, Gu YS, Liu XZ (2009) Human papillomavirus infection in Beijing, People’s Republic of China: a population-based study. Br J Cancer 101:1635–1640CrossRefPubMedPubMedCentral Zhao R, Zhang WY, Wu MH, Zhang SW, Pan J, Zhu L, Zhang YP, Li H, Gu YS, Liu XZ (2009) Human papillomavirus infection in Beijing, People’s Republic of China: a population-based study. Br J Cancer 101:1635–1640CrossRefPubMedPubMedCentral
Metadaten
Titel
Human papillomavirus genotype distribution among HPV-positive women in Sichuan province, Southwest China
verfasst von
Guo Tao
Gao Yaling
Gao Zhan
Liao Pu
He Miao
Publikationsdatum
05.10.2017
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 1/2018
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-017-3556-1

Weitere Artikel der Ausgabe 1/2018

Archives of Virology 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.